No Data
No Data
Duopharma Biotech Clinches MYR578 Million Supply Deals
Duopharma Biotech (KLSE:DPHARMA), through two wholly-owned subsidiaries, accepted 11 letters of offers from Pharmaniaga Logistics worth an aggregate 578 million ringgit for the supply of pharmaceutica
While Individual Investors Own 28% of Duopharma Biotech Berhad (KLSE:DPHARMA), Sovereign Wealth Funds Are Its Largest Shareholders With 51% Ownership
Malaysian Firms Clinch RM28.65 Mln Potential Sales at SeaCare 2024 - MATRADE
Malaysia Closing Bell on 17 Apr | AXIATA Was the Top Gainer of FBM KLCI
AXIATA was the top gainer, rising 4.00 percent to close at RM 2.600. The top loser was PPB, losing 1.52 percent to end at RM 15.540.
Malaysia Closing Bell on 12 Apr | HLBANK Was the Top Gainer of FBM KLCI
HLBANK was the top gainer, rising 0.62 percent to close at RM 19.460. The top loser was AXIATA, losing 1.91 percent to end at RM 2.570.
Are Duopharma Biotech Berhad's (KLSE:DPHARMA) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
No Data
102849402 : 弹花一现
RockoChanOP 102849402: Mybe pullback at middle bb
RockoChanOP : $DPHARMA (7148.MY)$
RockoChanOP : $DPHARMA (7148.MY)$